These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 22386643)

  • 1. All cut up! The consequences of calpain activation on platelet function.
    Randriamboavonjy V; Fleming I
    Vascul Pharmacol; 2012; 56(5-6):210-5. PubMed ID: 22386643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulating cell migration: calpains make the cut.
    Franco SJ; Huttenlocher A
    J Cell Sci; 2005 Sep; 118(Pt 17):3829-38. PubMed ID: 16129881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vinculin is proteolyzed by calpain during platelet aggregation: 95 kDa cleavage fragment associates with the platelet cytoskeleton.
    Serrano K; Devine DV
    Cell Motil Cytoskeleton; 2004 Aug; 58(4):242-52. PubMed ID: 15236355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of calpain in diabetes-associated platelet hyperactivation.
    Randriamboavonjy V; Fleming I
    Adv Pharmacol; 2010; 59():235-57. PubMed ID: 20933204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SNARE protein degradation upon platelet activation: calpain cleaves SNAP-23.
    Lai KC; Flaumenhaft R
    J Cell Physiol; 2003 Feb; 194(2):206-14. PubMed ID: 12494459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. cGMP and cGMP-dependent protein kinase in platelets and blood cells.
    Walter U; Gambaryan S
    Handb Exp Pharmacol; 2009; (191):533-48. PubMed ID: 19089344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double knockouts reveal that protein tyrosine phosphatase 1B is a physiological target of calpain-1 in platelets.
    Kuchay SM; Kim N; Grunz EA; Fay WP; Chishti AH
    Mol Cell Biol; 2007 Sep; 27(17):6038-52. PubMed ID: 17576811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calpains and calpastatin in human blood platelets.
    Ariyoshi H; Kambayashi J; Sakon M
    Platelets; 1995; 6(4):185-9. PubMed ID: 21043726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet factor XIII becomes active without the release of activation peptide during platelet activation.
    Muszbek L; Polgár J; Boda Z
    Thromb Haemost; 1993 Mar; 69(3):282-5. PubMed ID: 8097064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GPIbalpha-selective activation of platelets induces platelet signaling events comparable to GPVI activation events.
    Gardiner EE; Arthur JF; Shen Y; Karunakaran D; Moore LA; Am Esch JS; Andrews RK; Berndt MC
    Platelets; 2010; 21(4):244-52. PubMed ID: 20367574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunolocalization of the calpains and calpastatin in human and bovine platelets.
    Taylor RG; Christiansen JA; Goll DE
    Biomed Biochim Acta; 1991; 50(4-6):491-8. PubMed ID: 1801714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential regulation of platelet aggregation and aminophospholipid exposure by calpain.
    Bachelot-Loza C; Badol P; Brohard-Bohn B; Fraiz N; Cano E; Rendu F
    Br J Haematol; 2006 May; 133(4):419-26. PubMed ID: 16643450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Binding of calpain to plasma membrane and its role in platelets].
    Ishii H; Kuboki M; Fujii J; Kazama M
    Rinsho Byori; 1990 Jul; Suppl 86():44-53. PubMed ID: 2232240
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevention of platelet glycoprotein IIb/IIIa activation by 3,4-methylenedioxy-beta-nitrostyrene, a novel tyrosine kinase inhibitor.
    Wang WY; Wu YC; Wu CC
    Mol Pharmacol; 2006 Oct; 70(4):1380-9. PubMed ID: 16837624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myoblast attachment and spreading are regulated by different patterns by ubiquitous calpains.
    Mazères G; Leloup L; Daury L; Cottin P; Brustis JJ
    Cell Motil Cytoskeleton; 2006 Apr; 63(4):193-207. PubMed ID: 16496301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calpain-mediated regulation of platelet signaling pathways.
    Kuchay SM; Chishti AH
    Curr Opin Hematol; 2007 May; 14(3):249-54. PubMed ID: 17414215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of calpain cleavage sites in the G1 cyclin-dependent kinase inhibitor p19(INK4d).
    Joy J; Nalabothula N; Ghosh M; Popp O; Jochum M; Machleidt W; Gil-Parrado S; Holak TA
    Biol Chem; 2006 Mar; 387(3):329-35. PubMed ID: 16542156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The S1P(2) receptor expressed in human platelets is linked to the RhoA-Rho kinase pathway and is down regulated in type 2 diabetes.
    Randriamboavonjy V; Badenhoop K; Schmidt H; Geisslinger G; Fisslthaler B; Fleming I
    Basic Res Cardiol; 2009 May; 104(3):333-40. PubMed ID: 19139947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conventional calpains and programmed cell death.
    Łopatniuk P; Witkowski JM
    Acta Biochim Pol; 2011; 58(3):287-96. PubMed ID: 21887410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Adaptor proteins of blood platelets].
    Kralisz U
    Postepy Biochem; 2005; 51(3):308-17. PubMed ID: 16381175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.